List of Excipients in API BELZUTIFAN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BELZUTIFAN
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Merck Sharp & Dohme LLC | WELIREG | belzutifan | 0006-5331 | CELLULOSE, MICROCRYSTALLINE | 2034-09-05 |
Merck Sharp & Dohme LLC | WELIREG | belzutifan | 0006-5331 | CROSCARMELLOSE SODIUM | 2034-09-05 |
Merck Sharp & Dohme LLC | WELIREG | belzutifan | 0006-5331 | FD&C BLUE NO. 2--ALUMINUM LAKE | 2034-09-05 |
Merck Sharp & Dohme LLC | WELIREG | belzutifan | 0006-5331 | HYPROMELLOSE ACETATE SUCCINATE 06081224 | 2034-09-05 |
Merck Sharp & Dohme LLC | WELIREG | belzutifan | 0006-5331 | MAGNESIUM STEARATE | 2034-09-05 |
Merck Sharp & Dohme LLC | WELIREG | belzutifan | 0006-5331 | MANNITOL | 2034-09-05 |
Merck Sharp & Dohme LLC | WELIREG | belzutifan | 0006-5331 | POLYETHYLENE GLYCOL | 2034-09-05 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for BELZUTIFAN
Excipient focus: CELLULOSE, MICROCRYSTALLINE
BELZUTIFAN drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
BELZUTIFAN drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
BELZUTIFAN drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224
BELZUTIFAN drug variants containing HYPROMELLOSE ACETATE SUCCINATE 06081224
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 06081224
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
BELZUTIFAN drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
BELZUTIFAN drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
BELZUTIFAN drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
BELZUTIFAN drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
BELZUTIFAN drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
BELZUTIFAN drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
BELZUTIFAN drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | belzutifan | 0006-5331 |
>Company | >Ingredient | >NDC |
BELZUTIFAN drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.